An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma

Thromb Haemost. 2010 Nov;104(5):1078-9. doi: 10.1160/TH10-03-0204. Epub 2010 Aug 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Blood Coagulation / drug effects*
  • Clinical Trials, Phase II as Topic
  • Colorimetry*
  • Dose-Response Relationship, Drug
  • Drug Monitoring / methods*
  • Factor Xa Inhibitors*
  • Fibrinolytic Agents / blood*
  • Humans
  • Male
  • Morpholines / blood*
  • Orthopedic Procedures / adverse effects
  • Predictive Value of Tests
  • Rivaroxaban
  • Thiophenes / blood*
  • Thrombosis / blood
  • Thrombosis / etiology
  • Thrombosis / prevention & control

Substances

  • Factor Xa Inhibitors
  • Fibrinolytic Agents
  • Morpholines
  • Thiophenes
  • Rivaroxaban